???
Nothing has changed since June. Still an IPO for ordinary shares (I.e. not ADRs/hybrids/derivatives) to be dual listed on the Nasdaq. SEC clearance is a big step toward the listing.
@silvahman - what requirement are you talking about, and why in the world would management be shorting? Aside from the legal/disclosure issues around that, it would make absolutely no sense. There's also no way you get SEC clearance for a Nasdaq listing if the company or management are actively shorting or lending stock.
Ann: NASDAQ Progression - Medlab Clears SEC Comments, page-4
Add to My Watchlist
What is My Watchlist?